CO7160072A2 - Synthesis of heterocyclic compounds - Google Patents

Synthesis of heterocyclic compounds

Info

Publication number
CO7160072A2
CO7160072A2 CO14278717A CO14278717A CO7160072A2 CO 7160072 A2 CO7160072 A2 CO 7160072A2 CO 14278717 A CO14278717 A CO 14278717A CO 14278717 A CO14278717 A CO 14278717A CO 7160072 A2 CO7160072 A2 CO 7160072A2
Authority
CO
Colombia
Prior art keywords
compounds
deleishmaniasis
quaternary ammonium
ammonium salts
halogenated
Prior art date
Application number
CO14278717A
Other languages
Spanish (es)
Inventor
Prabha N Ibrahim
Original Assignee
Plexxikon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/793,917 external-priority patent/US9150570B2/en
Application filed by Plexxikon Inc filed Critical Plexxikon Inc
Publication of CO7160072A2 publication Critical patent/CO7160072A2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Sales de amonio cuaternario halogenado son descritas para tratar infecciones deleishmaniasis y otras infecciones parasitarias. Aunque se han descrito los informesanteriores en los que las sales de amonio cuaternarios se usan como compuestosantimalarios, antifungicos, y antileishmaniales, no se ha reportado el uso de talessales que contienen un sustituto de N-metilo halogenado como agente terapéutico contra la leishmaniasis. Los compuestos aquí descritos, específicamente aquellos conporción terminal de arilalquenilo o diarilalquenilo, inhiben el crecimiento de losparásitos Leishmania panamensis, un agente conocido por causar la enfermedad deleishmaniasis. Adicionalmente, la serie de compuestos también se extiende contra lamalaria, la Enfermedad de Chagas, la toxoplasmosis, y otras enfermedadesparasitarias.Halogenated quaternary ammonium salts are described to treat deleishmaniasis infections and other parasitic infections. Although the above reports have been described in which quaternary ammonium salts are used as antimalarial, antifungal, and antileishmanial compounds, the use of talsales containing a halogenated N-methyl substitute as a therapeutic agent against leishmaniasis has not been reported. The compounds described herein, specifically those terminal proportions of arylalkenyl or diarylalkenyl, inhibit the growth of Leishmania panamensis parasites, an agent known to cause deleishmaniasis disease. Additionally, the series of compounds also extends against lamalaria, Chagas disease, toxoplasmosis, and other parasitic diseases.

CO14278717A 2012-05-31 2014-12-18 Synthesis of heterocyclic compounds CO7160072A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261653944P 2012-05-31 2012-05-31
US13/793,917 US9150570B2 (en) 2012-05-31 2013-03-11 Synthesis of heterocyclic compounds

Publications (1)

Publication Number Publication Date
CO7160072A2 true CO7160072A2 (en) 2015-01-15

Family

ID=52623072

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14278717A CO7160072A2 (en) 2012-05-31 2014-12-18 Synthesis of heterocyclic compounds

Country Status (1)

Country Link
CO (1) CO7160072A2 (en)

Similar Documents

Publication Publication Date Title
ECSP19030002A (en) 1,2,4-TRIAZOLONES 2,4,5-TRISUSTITUIDED
DOP2015000241A (en) BIARIL-AMIDA COMPOUNDS AS CINASA INHIBITORS
CR20180232A (en) PEPTIDE MACROCICLES AGAINST ACINETOBACTER BAUMANNII
MX2015011955A (en) Lipids and lipid compositions for the delivery of active agents.
BR112014013175A8 (en) extended release compositions based on amphipathic lipids and process for preparing extended release composition tablets
UY35040A (en) PIRROLOPIRIMIDINILAMINO-BENZOTIAZOLONAS REPLACED
UY32259A (en) NEW HYDROXYARENE COMPOUNDS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND APPLICATIONS
ECSP13012448A (en) NEW AMINOPIRAZOLOQUINAZOLINAS.
UY34750A (en) ? COMPOUNDS FOR HIV TREATMENT, COMPOSITIONS, PREPARATION METHODS, INTERMEDIARIES AND THERAPEUTIC METHODS ?.
BR112015010360A8 (en) il-6 antagonists and their use.
PA8680701A1 (en) OXINDOL DERIVATIVES
DOP2013000130A (en) PIRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS THROUGH LP - PLA2
CO6720961A2 (en) Imidazopyridazines substituted
CL2012000589A1 (en) Compounds derived from pyrrolo pyridine carboxamides, jak2 inhibitors; pharmaceutical composition comprising them; use in the treatment of myeloproliferative diseases or cancer, such as polycythemia vera, essential thrombocytopenia, multiple myeloma, among others.
UY32502A (en) ANTIHELMINTIC AGENTS AND ITS USE
CO6630158A2 (en) Derivatives of ketoheteroarylpiperidine and ketoheteroarylpiperazine as fungicides
UY30282A1 (en) CHEMICAL COMPOUNDS
DOP2016000253A (en) NEW COMPOUNDS
BR112013012621A2 (en) microbicidal heterocycles
ECSP15013883A (en) BENZAMIDES
BR112013020419A2 (en) pyrazole-derived microbicides
EA201391212A1 (en) NEW APPLICATIONS OF CHLORIDE IN AGROCHEMICAL PREPARATIONS
UY35276A (en) New compounds that inhibit the activity of Lp-PLA2
AR092960A1 (en) PROCEDURE TO PREPARE TIENOPIRIMIDINE COMPOUNDS
DOP2016000007A (en) SUBSTITUTED PIRAZOLPIRIDINS